Representative examples of such genes include those encoding lipoprotein lipase (LPL), where variants increase risk of coronary artery disease via perturbation of triglyceride metabolism, and checkpoint kinase 2 (CHEK2), which increases risk of breast cancer via perturbation of DNA repair pathways37,38. This evidence concerns the gene LPL and coronary artery disorder.